
Professor of Biochemistry and Molecular Biology
University of Parma, Parma
Italy
Phone: +39-0521-033803
E-mail: saverio.bettuzzi@unipr.it
University of Parma, Parma
Italy
Phone: +39-0521-033803
E-mail: saverio.bettuzzi@unipr.it
PhD | 1981 | University of Bologna, Italy |
University Diploma | 1983 | University of Bologna, Italy |
Doctorate | 1990 | University of Bologna, Italy |
Dr. Saverio Bettuzzi received a PhD in Biology in 1981, the University Diploma in Marine Biochemistry in 1983, and the Doctorate in Biochemistry in 1990, all from the University of Bologna, Italy. He was a Postdoctoral Fellow in Biochemistry (1984–1986) at the University of Modena, Italy, and a Research Associate at the Ben May Institute for Cancer Research at the University of Chicago, USA (1987–1989). After returning to Italy, he became a Postdoctoral Fellow in Biochemistry at the University of Modena (1996–2000), Associate Professor of Biochemistry (2001-2005), and Full Professor of Biochemistry (2005-present) at the University of Parma. He is also member of the Board of Directors of the University of Parma, Vice-Director of COMT (Centre for Molecular and Translational Oncology, Parma), member of the Board of INBB (National Institute of Biostructure and Biosystems, Rome). He served as member of the Board of ESUR (European Section of Urological Research) in the time period 2013-2018 and he is now Associate member of the Board. He heads a research group with multiple international collaborations, and hosted international meetings. He cloned and identified Clusterin (CLU) as the major over-expressed gene during castration-induced involution of rat prostate in 1989. His research has focused on understanding the regulation of expression and the biological role of CLU as a tumor suppressor for Prostate, Colon, Ovarian, Lung Cancers and Neuroblastoma. He did original research on the anti-cancer activity of Green Tea extracts (GTE) showing that progression of Prostate Cancer can be blocked with GTE in mouse models and humans. He also validated a qPCR method for molecular diagnosis and prognosis of Prostate Cancer in humans. His group recently discovered and characterized a novel P2 promoter of CLU in humans, which is regulated epigenetically.
Clusterin (CLU), Prostate Cancer (PCa), Green Tea, Catechins, Polyphenols, EGCG, Chemoprevention, Biochemistry and Molecular Biology of Cancer, Physiology and Pathology of the Prostate, Cell Growth Control, Prostate Metabolism, Androgen Action on Prostate Cells, Polyamines, Gene expression, Epigenetic Regulation of Gene Expression
All Sci Forschen Journals are Open Access